Esperion Therapeutics Inc. (ESPR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR, MI 48108

Esperion Therapeutics Inc is engaged in the research, development and commercialization of therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardiometabolic risk factors.

Data as of 2020-09-12
Market Cap1.053 Billion Shares Outstanding27.825 Million Avg 30-day Volume694.602 Thousand
P/E Ratio Dividend Yield EPS-3.33
Price/Sales4.874 Price cash flow ratio Price free cash flow ratio-26.8
Book Value3.07 Price to Tangible Book12.32 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.100669
BETA1.8024 52-week High/Low76.98 / 24.82 Stddev0.242724

Are you looking for this stock instead?

View SEC Filings from ESPR instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 3 33.33% 1 (0.07%) 0 (0.0%)
Funds Holding: 178 162 9.88% 50 (3.26%) 43 (2.75%) 16.28%
13F shares: 31.65 Million 29.483 Million 7.35% 8.132 Million 7.18 Million 13.26%
% Ownership 29.4443 26.0633 12.97%
New Positions: 40 31 29.03% 17 13 30.77%
Increased Positions 65 55 18.18% 14 17 -17.65%
Closed Positions 23 38 -39.47% 10 15 -33.33%
Reduced Positions 39 49 -20.41% 14 6 133.33%
Total Calls 1.028 Million 299.147 Thousand 243.5% 293 Thousand 147.7 Thousand 98.38%
Total Puts 689.758 Thousand 402.866 Thousand 71.21% 240.8 Thousand 84.5 Thousand 184.97%
PUT/CALL Ratio 0.67 1.35 -50.37% 0.82 0.57 43.86%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ESPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ESPR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JANNEY DANIEL

  • Director
35,638 2020-05-28 1

VITULLO NICOLE

  • Director
19,392 2020-05-28 1

GOTTO ANTONIO M JR MD D PHIL

  • Director
11,073 2020-05-28 1

MCGOVERN MARK E

  • Director
16,073 2020-05-28 1

BERKOWITZ JEFFREY

  • Director
11,073 2020-05-28 1

SHEPARD JAY

  • Director
11,073 2020-05-28 1

WOODY TRACY M

  • Director
16,040 2020-05-28 1

FUHRMAN ALAN

  • Director
12,878 2020-05-28 3

MAYLEBEN TIMOTHY M PRESIDENT & CEO

  • Officer
  • Director
111,998 2020-03-11 4

HALL ASHLEY CHIEF DEVELOPMENT OFFICER

  • Officer
15,500 2020-02-26 1

BIOTECH TARGET N V

BB BIOTECH AG

  • 10% Owner
3,747,964 2020-01-23 2

BARTRAM RICHARD CHIEF FINANCIAL OFFICER

  • Officer
18,673 2020-01-02 1

GLICKMAN MARK A CHIEF COMMERCIAL OFFICER

  • Officer
25,925 2020-01-02 1

BRAUNSTEIN SCOTT

  • Director
5,019 2019-05-29 0

NEWTON ROGER S

  • Director
548,726 2019-03-12 0

LALWANI NARENDRA D. CHIEF OPERATING OFFICER

  • Officer
0 2018-11-28 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

  • 10% Owner
No longer subject to file 2018-11-02 0

BRASLYN LTD.

BOXER ASSET MANAGEMENT INC.

TUESDAY THIRTEEN INC.

LEWIS JOSEPH

BOXER CAPITAL, LLC

  • 10% Owner
2,602,350 2018-10-26 0

GOLDSTEIN DOV A MD

  • Director
47 2018-06-06 0

OMENN GILBERT S

  • Director
0 2017-04-17 0

MCGOWAN MARY CHIEF MEDICAL OFFICER

  • Officer
0 2017-02-21 0

ENRIGHT PATRICK G

  • Director
0 2015-05-14 0

AISLING CAPITAL II LP

AISLING CAPITAL PARTNERS, LP

AISLING CAPITAL PARTNERS LLC

SCHIFF ANDREW N

PURCELL DENNIS J

ELMS STEVE

  • 10% Owner
No longer subject to file 2015-04-23 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • Director
  • 10% Owner
2,216,935 2015-03-20 0

ALTA PARTNERS VIII, L.P.

  • 10% Owner
No longer subject to file 2015-02-18 0

SHAH NIMESH

  • 10% Owner
21,471 2015-01-01 0

LONGITUDE CAPITAL PARTNERS, LLC

LONGITUDE CAPITAL ASSOCIATES, L.P.

LONGITUDE VENTURE PARTNERS L.P.

TAMMENOMS BAKKER JULIET

  • 10% Owner
No longer subject to file 2014-11-17 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

CHAMPSI FARAH

NOHRA GUY P

  • 10% Owner
2,552,189 2014-10-21 0

ROSENBERG NOAH L. CHIEF MEDICAL OFFICER

  • Officer
0 2013-07-23 0

LANGE LOUIS G

  • Director
215,517 2013-07-01 0

BLAIR JAMES C

  • 10% Owner
2,102,188 2013-07-01 0

DOVEY BRIAN H

  • 10% Owner
2,102,188 2013-07-01 0

TREU JESSE I

  • 10% Owner
2,102,188 2013-07-01 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
2,102,188 2013-07-01 0

DP VII ASSOCIATES LP

  • 10% Owner
35,253 2013-07-01 0

DOMAIN PARTERS VII L P

  • 10% Owner
2,066,935 2013-07-01 0

HALAK BRIAN K

  • 10% Owner
2,102,188 2013-07-01 0

IGNELZI TROY A. VICE PRESIDENT

  • Officer
0 2013-06-25 0

DOMAIN ASSOCIATES

  • 10% Owner
21,471 2013-06-25 0

KAMDAR KIM P.

  • 10% Owner
21,471 2013-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments